|
1
|
McKay JA, Williams EA and Mathers JC:
Effect of maternal and post-weaning folate supply on gene-specific
DNA methylation in the small intestine of weaning and adult apc and
wild type mice. Front Genet. 2:232011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohtaki T, Shintani Y, Honda S, et al:
Metastasis suppressor gene Kiss-1 encodes peptide ligand of a
G-protein-coupled receptor. Nature. 411:613–617. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sanchez-Carbayo M, Schwarz K,
Charytonowicz E, Cordon-Cardo C and Mundel P: Tumor suppressor role
for myopodin in bladder cancer: loss of nuclear expression of
myopodin is cell-cycle dependent and predicts clinical outcome.
Oncogene. 22:5298–5305. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang H, Jones J, Turner T, et al: Clinical
and biological significance of KISS1 expression in prostate cancer.
Am J Pathol. 180:1170–1178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cutait R, Calache JE, Borges JL, et al:
The value of colonoscopy in low digestive hemorrhages of
unexplained cause: analysis of 132 patients. Rev Paul Med.
96:66–68. 1980.(In Portuguese).
|
|
6
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee JH, Miele ME, Hicks DJ, et al: KiSS-1,
a novel human malignant melanoma metastasis-suppressor gene. J Natl
Cancer Inst. 88:1731–1737. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Welch DR, Chen P, Miele ME, et al:
Microcell-mediated transfer of chromosome 6 into metastatic human
C8161 melanoma cells suppresses metastasis but does not inhibit
tumorigenicity. Oncogene. 9:255–262. 1994.PubMed/NCBI
|
|
9
|
Lee JH and Welch DR: Identification of
highly expressed genes in metastasis-suppressed chromosome 6/human
malignant melanoma hybrid cells using subtractive hybridization and
differential display. Int J Cancer. 71:1035–1044. 1997. View Article : Google Scholar
|
|
10
|
Bilban M, Ghaffari-Tabrizi N, Hintermann
E, et al: Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is
a physiological invasion inhibitor of primary human trophoblasts. J
Cell Sci. 117:1319–1328. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kotani M, Detheux M, Vandenbogaerde A, et
al: The metastasis suppressor gene KiSS-1 encodes kisspeptins, the
natural ligands of the orphan G protein-coupled receptor GPR54. J
Biol Chem. 276:34631–34636. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miele ME, Jewett MD, Goldberg SF, et al: A
human melanoma metastasis-suppressor locus maps to 6q16.3–q23. Int
J Cancer. 86:524–528. 2000.PubMed/NCBI
|
|
13
|
Shirasaki F, Takata M, Hatta N and
Takehara K: Loss of expression of the metastasis suppressor gene
KiSS1 during melanoma progression and its association with LOH of
chromosome 6q16.3–q23. Cancer Res. 61:7422–7425. 2001.PubMed/NCBI
|
|
14
|
Goldberg SF, Miele ME, Hatta N, et al:
Melanoma metastasis suppression by chromosome 6: evidence for a
pathway regulated by CRSP3 and TXNIP. Cancer Res. 63:432–440.
2003.PubMed/NCBI
|
|
15
|
Lee DK, Nguyen T, O’Neill GP, et al:
Discovery of a receptor related to the galanin receptors. FEBS
Lett. 446:103–107. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Muir AI, Chamberlain L, Elshourbagy NA, et
al: AXOR12, a novel human G protein-coupled receptor, activated by
the peptide KiSS-1. J Biol Chem. 276:28969–28975. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hori A, Honda S, Asada M, et al: Metastin
suppresses the motility and growth of CHO cells transfected with
its receptor. Biochem Biophys Res Commun. 286:958–963. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee JH and Welch DR: Suppression of
metastasis in human breast carcinoma MDA-MB-435 cells after
transfection with the metastasis suppressor gene, KiSS-1. Cancer
Res. 57:2384–2387. 1997.PubMed/NCBI
|
|
19
|
Lee KH and Kim JR: Kiss-1 suppresses MMP-9
expression by activating p38 MAP kinase in human stomach cancer.
Oncol Res. 18:107–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan C, Wang H and Boyd DD: KiSS-1
represses 92-kDa type IV collagenase expression by down-regulating
NF-kappa B binding to the promoter as a consequence of Ikappa
Balpha-induced block of p65/p50 nuclear translocation. J Biol Chem.
276:1164–1172. 2001. View Article : Google Scholar
|
|
21
|
Ringel MD, Hardy E, Bernet VJ, et al:
Metastin receptor is overexpressed in papillary thyroid cancer and
activates MAP kinase in thyroid cancer cells. J Clin Endocrinol
Metab. 87:23992002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mitchell DC, Stafford LJ, Li D, Bar-Eli M
and Liu M: Transcriptional regulation of KiSS-1 gene expression in
metastatic melanoma by specificity protein-1 and its coactivator
DRIP-130. Oncogene. 26:1739–1747. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marot D, Bieche I, Aumas C, et al: High
tumoral levels of Kiss1 and G-protein-coupled receptor 54
expression are correlated with poor prognosis of estrogen
receptor-positive breast tumors. Endocr Relat Cancer. 14:691–702.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kostadima L, Pentheroudakis G and Pavlidis
N: The missing kiss of life: transcriptional activity of the
metastasis suppressor gene KiSS1 in early breast cancer. Anticancer
Res. 27:2499–2504. 2007.PubMed/NCBI
|
|
25
|
Stark AM, Tongers K, Maass N, Mehdorn HM
and Held-Feindt J: Reduced metastasis-suppressor gene
mRNA-expression in breast cancer brain metastases. J Cancer Res
Clin Oncol. 131:191–198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martin TA, Watkins G and Jiang WG: KiSS-1
expression in human breast cancer. Clin Exp Metastasis. 22:503–511.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dhar DK, Naora H, Kubota H, et al:
Downregulation of KiSS-1 expression is responsible for tumor
invasion and worse prognosis in gastric carcinoma. Int J Cancer.
111:868–872. 2004. View Article : Google Scholar
|
|
28
|
Yao HL, Yang ZL, Li YG and Liu GW: In situ
hybridization study on the expression of Kiss-1 and KAI-1
metastasis suppressor genes in gastric cancer. Zhonghua Wei Chang
Wai Ke Za Zhi. 10:274–277. 2007.(In Chinese).
|
|
29
|
Tachibana M, Kinugasa S, Dhar DK, et al:
Prognostic factors in T1 and T2 squamous cell carcinoma of the
thoracic esophagus. Arch Surg. 134:50–54. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ikeguchi M, Yamaguchi K and Kaibara N:
Clinical significance of the loss of KiSS-1 and orphan
G-protein-coupled receptor (hOT7T175) gene expression in esophageal
squamous cell carcinoma. Clin Cancer Res. 10:1379–1383. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cedrone A, Rapaccini GL, Pompili M, et al:
Portal vein thrombosis complicating hepatocellular carcinoma. Value
of ultrasound-guided fine-needle biopsy of the thrombus in the
therapeutic management. Liver. 16:94–98. 1996. View Article : Google Scholar
|
|
32
|
Hou YK, Wang Y, Cong WM and Wu MC:
Expression of tumor metastasis-suppressor gene KiSS-1 and matrix
metalloproteinase-9 in portal vein tumor thrombus of hepatocellular
carcinoma. Ai Zheng. 26:591–595. 2007.(In Chinese).
|
|
33
|
Ikeguchi M, Hirooka Y and Kaibara N:
Quantitative reverse transcriptase polymerase chain reaction
analysis for KiSS-1 and orphan G-protein-coupled receptor
(hOT7T175) gene expression in hepatocellular carcinoma. J Cancer
Res Clin Oncol. 129:531–535. 2003. View Article : Google Scholar
|
|
34
|
Schmid K, Wang X, Haitel A, et al: KiSS-1
overexpression as an independent prognostic marker in
hepatocellular carcinoma: an immunohistochemical study. Virchows
Arch. 450:143–149. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rigaud G, Moore PS, Zamboni G, et al:
Allelotype of pancreatic acinar cell carcinoma. Int J Cancer.
88:772–777. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yatsuoka T, Sunamura M, Furukawa T, et al:
Association of poor prognosis with loss of 12q, 17p, and 18q, and
concordant loss of 6q/17p and 12q/18q in human pancreatic ductal
adenocarcinoma. Am J Gastroenterol. 95:2080–2085. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Masui T, Doi R, Mori T, et al: Metastin
and its variant forms suppress migration of pancreatic cancer
cells. Biochem Biophys Res Commun. 315:85–92. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liang S and Yang ZL: Expression of
KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous
pancreatic tissues in SD rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
32:109–113. 2007.(In Chinese).
|
|
39
|
Singer PA, Cooper DS, Daniels GH, et al:
Treatment guidelines for patients with thyroid nodules and
well-differentiated thyroid cancer. American Thyroid Association.
Arch Intern Med. 156:2165–2172. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Stathatos N, Bourdeau I, Espinosa AV, et
al: KiSS-1/G protein-coupled receptor 54 metastasis suppressor
pathway increases myocyte-enriched calcineurin interacting protein
1 expression and chronically inhibits calcineurin activity. J Clin
Endocrinol Metab. 90:5432–5440. 2005. View Article : Google Scholar
|
|
41
|
Jemal A, Murray T, Samuels A, Ghafoor A,
Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin.
53:5–26. 2003. View Article : Google Scholar
|
|
42
|
Jiang Y, Berk M, Singh LS, et al: KiSS1
suppresses metastasis in human ovarian cancer via inhibition of
protein kinase C alpha. Clin Exp Metastasis. 22:369–376. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gao GL, Liu LD, Zou XS and Chen WX:
Expression of KiSS-1, matrix metalloproteinase-9, nuclear
factor-kappaBp65 in ovarian tumour. Zhonghua Fu Chan Ke Za Zhi.
42:34–38. 2007.(In Chinese).
|
|
44
|
Hata K, Dhar DK, Watanabe Y, Nakai H and
Hoshiai H: Expression of metastin and a G-protein-coupled receptor
(AXOR12) in epithelial ovarian cancer. Eur J Cancer. 43:1452–1459.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cole LA: Phantom hCG and phantom
choriocarcinoma. Gynecol Oncol. 71:325–329. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Horikoshi Y, Matsumoto H, Takatsu Y, et
al: Dramatic elevation of plasma metastin concentrations in human
pregnancy: metastin as a novel placenta-derived hormone in humans.
J Clin Endocrinol Metab. 88:914–919. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cole LA and Sutton JM: Selecting an
appropriate hCG test for managing gestational trophoblastic disease
and cancer. J Reprod Med. 49:545–553. 2004.PubMed/NCBI
|
|
48
|
Dhillo WS, Savage P, Murphy KG, et al:
Plasma kisspeptin is raised in patients with gestational
trophoblastic neoplasia and falls during treatment. Am J Physiol
Endocrinol Metab. 291:E878–E884. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar
|
|
50
|
Nicolle G, Comperat E, Nicolaïew N,
Cancel-Tassin G and Cussenot O: Metastin (KISS-1) and
metastin-coupled receptor (GPR54) expression in transitional cell
carcinoma of the bladder. Ann Oncol. 18:605–607. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Buchan NC and Goldenberg SL: Intermittent
androgen suppression for prostate cancer. Nat Rev Urol. 7:552–560.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ramiah V, George DJ and Armstrong AJ:
Clinical endpoints for drug development in prostate cancer. Curr
Opin Urol. 18:303–308. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Plantade A, Massard C, de Crevoisier R and
Fizazi K: Locally advanced prostate cancer: definition, prognosis
and treatment. Bull Cancer. 94:F50–F61. 2007.(In French).
|
|
54
|
Creasman WT, Odicino F, Maisonneuve P, et
al: Carcinoma of the corpus uteri. FIGO 26th Annual Report on the
Results of Treatment in Gynecological Cancer. Int J Gynaecol
Obstet. 95(Suppl 1): S105–S143. 2006.PubMed/NCBI
|
|
55
|
Kang HS, Baba T, Mandai M, et al: GPR54 is
a target for suppression of metastasis in endometrial cancer. Mol
Cancer Ther. 10:580–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nomura H, Sato H, Seiki M, Mai M and Okada
Y: Expression of membrane-type matrix metalloproteinase in human
gastric carcinomas. Cancer Res. 55:3263–3266. 1995.PubMed/NCBI
|
|
57
|
Gottsch ML, Clifton DK and Steiner RA:
Kisspepeptin-GPR54 signaling in the neuroendocrine reproductive
axis. Mol Cell Endocrinol. 254–255:91–96. 2006.PubMed/NCBI
|
|
58
|
Li D, Mitchell D, Luo J, et al: Estrogen
regulates KiSS1 gene expression through estrogen receptor alpha and
SP protein complexes. Endocrinology. 148:4821–4828. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Dissanayake SK, Wade M, Johnson CE, et al:
The Wnt5A/protein kinase C pathway mediates motility in melanoma
cells via the inhibition of metastasis suppressors and initiation
of an epithelial to mesenchymal transition. J Biol Chem.
282:17259–17271. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ohta S, Lai EW, Pang AL, et al:
Downregulation of metastasis suppressor genes in malignant
pheochromocytoma. Int J Cancer. 114:139–143. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Janneau JL, Maldonado-Estrada J, Tachdjian
G, et al: Transcriptional expression of genes involved in cell
invasion and migration by normal and tumoral trophoblast cells. J
Clin Endocrinol Metab. 87:5336–5339. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Jiang T, Zhang SL, Lin B, Meng LR and Gao
H: Expression and clinical significance of KISS-1 and GPR54 mRNA in
endometrial carcinoma. Zhonghua Zhong Liu Za Zhi. 27:229–231.
2005.(In Chinese).
|
